BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 1959952)

  • 1. Virulence factors in Bacteroides fragilis group.
    Jotwani R; Gupta U
    Indian J Med Res; 1991 Jul; 93():232-5. PubMed ID: 1959952
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenicity of Bacteroides fragilis group in rat intra-abdominal abscesses.
    Jotwani R; Gupta U; Watanabe K; Ueno K
    Microbiol Immunol; 1992; 36(10):1041-9. PubMed ID: 1479960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenicity of the Bacteroides fragilis group.
    Brook I
    Ann Clin Lab Sci; 1989; 19(5):360-76. PubMed ID: 2679351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection with Bacteroides fragilis: pathogenesis and immunoprophylaxis in an animal model.
    Kasper DL; Onderdonk AB
    Scand J Infect Dis Suppl; 1982; 31():28-33. PubMed ID: 6954635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The capsular polysaccharide of Bacteroides fragilis as a virulence factor: comparison of the pathogenic potential of encapsulated and unencapsulated strains.
    Onderdonk AB; Kasper DL; Cisneros RL; Bartlett JG
    J Infect Dis; 1977 Jul; 136(1):82-9. PubMed ID: 886206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Encapsulation and protection against phagocytosis by Bacteroides fragilis.
    Lindberg AA; Weintraub A
    Scand J Infect Dis Suppl; 1985; 46():27-32. PubMed ID: 3865350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Application of quantitative real-time PCR for rapid identification of Bacteroides fragilis group and related organisms in human wound samples.
    Tong J; Liu C; Summanen P; Xu H; Finegold SM
    Anaerobe; 2011 Apr; 17(2):64-8. PubMed ID: 21439390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of a model of intraabdominal sepsis for studies of the pathogenicity of Bacteroides fragilis.
    Onderdonk AB; Shapiro ME; Finberg RW; Zaleznik DF; Kasper DL
    Rev Infect Dis; 1984; 6 Suppl 1():S91-5. PubMed ID: 6372042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal synergy between Escherichia coli and Bacteroides fragilis in an intra-abdominal infection model.
    Rotstein OD; Kao J; Houston K
    J Med Microbiol; 1989 Aug; 29(4):269-76. PubMed ID: 2668529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virulence factors of anaerobic bacteria.
    Bartlett JG
    Johns Hopkins Med J; 1982 Jul; 151(1):1-9. PubMed ID: 7045489
    [No Abstract]   [Full Text] [Related]  

  • 11. Rapid identification of clinically important bacteroides by coagglutination method.
    Lalitha MK; Anandi V; Elias L; Kalpana CR
    Indian J Med Res; 1991 Mar; 93():98-102. PubMed ID: 1855827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal model system for studying virulence of and host response to Bacteroides fragilis.
    Onderdonk AB; Cisneros RL; Finberg R; Crabb JH; Kasper DL
    Rev Infect Dis; 1990; 12 Suppl 2():S169-77. PubMed ID: 2406869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute appendicitis and Bacteroides fragilis.
    Pieper R; Kager L; Lindberg AA; Nord CE
    Scand J Infect Dis Suppl; 1979; (19):92-7. PubMed ID: 379991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface antigens as virulence factors in infection with Bacteroides fragilis.
    Kasper DL; Onderdonk AB; Polk BF; Bartlett JG
    Rev Infect Dis; 1979; 1(2):278-90. PubMed ID: 549184
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology of abscess formation.
    Bieluch VM; Tally FP
    Clin Obstet Gynaecol; 1983 Apr; 10(1):93-103. PubMed ID: 6872404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pathogenicity of Bacteroides fragilis and related species estimated by intracutaneous infection in the guinea-pig.
    Maskell JP
    J Med Microbiol; 1981 Feb; 14(1):131-40. PubMed ID: 7463462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Endotoxin production in members of the Bacteroides fragilis group in relation to colorectal cancer humans].
    Chmelar D; Vrtný J
    Klin Mikrobiol Infekc Lek; 2010 Jun; 16(3):97-102. PubMed ID: 20640988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-vivo bactericidal activity of Sch 34343 in Bacteroides fragilis abscesses and in Bacteroides fragilis-Escherichia coli abscesses.
    Wells CL; Arland LA; Simmons RL; Rotstein OD
    J Antimicrob Chemother; 1985 Jun; 15 Suppl C():199-206. PubMed ID: 3897172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The spectrum of Escherichia coli--Bacteroides fragilis pathogenic synergy in an intraabdominal infection model.
    Rotstein OD; Kao J
    Can J Microbiol; 1988 Mar; 34(3):352-7. PubMed ID: 3046726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for T cell-dependent immunity to Bacteroides fragilis in an intraabdominal abscess model.
    Onderdonk AB; Markham RB; Zaleznik DF; Cisneros RL; Kasper DL
    J Clin Invest; 1982 Jan; 69(1):9-16. PubMed ID: 6976357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.